The group focuses on characterizing cellular immune responses that effectively control viral infections
VIRIEVAC combines virology, cellular immunology, and bioinformatics in the study of virus-immune interactions so as to understand the role played by T-cells in controlling HIV-1 and SARS-CoV-2 infections. Its ultimate goal is, by defining the functional features behind long-term effective cellular immunity against viral infections, to develop innovative immune monitoring tools and immune interventions.
-
-
-
Prevalence and severity of anxiety, stress, and depression in long COVID among adults in Barcelona.
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses.
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
-
-
-
News from the group
